160 HEALTH(02656.HK)

Last Updated 08:00:00
longbridge loading
Company Encyclopedia
View More
name
160 HEALTH
02656.HK
160 Health International Limited wholesales and retails pharmaceutical and healthcare products in China. It develops Healthcare 160 Platform, an online healthcare and wellness service platform which provides digital healthcare and wellness solutions, including online marketing solutions, digital hospital solutions, and online healthcare services to business customers, medical and healthcare institutions, medical professionals, individual users, and third-party merchants. The company was founded in 2005 and is headquartered in Shenzhen, the People’s Republic of China.
184.51 B
02656.HKMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Morning Trend | 160 HEALTH (2656.HK) moves sideways with a slight rise and low trading volume, caution is needed as themes may cool down

    Health 160 (2656.HK) had a mild performance yesterday, with the main market funds showing a lackluster performance. The online medical sector had little news, with limited realization of favorable policies, and the enthusiasm for digital healthcare and medical insurance themes has declined. Recently, there has been a diversion of funds among institutions, and prices are in a phase of low-volume consolidation. Although there are short-term technical signals of a rebound, the overall themes lack effective momentum, and the continuation of a weak market is highly likely. Attention should be paid to sector rotation and marginal changes in news, as short-term trends remain susceptible to external environments and sudden information, necessitating increased vigilance to guard against systemic volatility risks caused by emotional pullbacks

    Technical Forecast·
    HK
    02656
    +1.38%
    Technical Forecast·
    HK
    02656
    +1.38%

    Top 10 HK Stock Gainers (12.16)

    ZHEJIANG SHIBAO(01057) rose 12.9%, with a trading turnover 326.5 Million HKD, and a year-to-date rose 58.8%. EASY SMART GP(02442) rose 12.39%, with a trading turnover 16.8 Million HKD, and a year-to-date rose 900%. MINIEYE(02431) rose 8.98%, with a trading turnover 182.9 Million HKD, and a year-to-date fell 44.5%.

    Top Gainers & Losers·
    HK
    01057
    0.00%
    HK
    02442
    -2.74%
    HK
    02431
    -2.25%
    Top Gainers & Losers·
    HK
    01057
    0.00%
    HK
    02442
    -2.74%
    HK
    02431
    -2.25%

    Understanding the Market | 160 HEALTH surged over 8% during trading, setting a new historical high, having risen over 256% since its listing a month ago

    160 HEALTH rose over 8% during trading, reaching a new high of HKD 42.34, an increase of over 256% compared to the offering price of HKD 11.89. As of the time of writing, it rose by %, reported at 5.84%, priced at HKD 41.32, with a transaction volume of HKD 31.8255 million. 160 HEALTH was listed on September 17 of this year. According to the prospectus, 160 HEALTH is an experienced wholesale distributor of pharmaceutical and health products in China and a leading provider of integrated digital healthcare services. The company offers a variety of pharmaceutical and health products, as well as comprehensive digital healthcare solutions. In addition, the company provides digital healthcare solutions through its online healthcare service platform - the 160 HEALTH platform, empowering participants across the entire healthcare industry chain. As of March 31, 2025, the 160 HEALTH platform has connected over 44,600 healthcare institutions since its establishment, including over 14,400 hospitals (including 3,430 tertiary hospitals) and over 30,200 grassroots medical and health institutions. As of the same date, more than 6,800 private institutions among the cooperative healthcare institutions primarily provide consumer medical services on the company's platform, such as dental, ophthalmology, and health check-up services

    Zhitong·
    HK
    02656
    +1.38%
    Zhitong·
    HK
    02656
    +1.38%

    Understanding the Market | 160 HEALTH rises over 10%, more than 2.3 times the IPO price. The company is a comprehensive service provider for digital healthcare

    160 HEALTH has risen over 10% again, reaching HKD 39.5, an increase of over 230% compared to the offering price of HKD 11.89. As of the time of writing, it has risen 9.52%, trading at HKD 39.1, with a transaction volume of HKD 20.9957 million. The prospectus shows that 160 HEALTH is an experienced wholesale distributor of Chinese pharmaceutical and health products and a leading provider of integrated digital healthcare services. The company offers a variety of pharmaceutical and health products to customers, as well as comprehensive digital healthcare solutions. In addition, the company provides digital healthcare solutions through its online healthcare service platform - the 160 HEALTH platform, empowering participants across the entire healthcare industry chain. As of March 31, 2025, the 160 HEALTH platform has connected over 44,600 healthcare institutions since its establishment

    Zhitong·
    HK
    02656
    +1.38%
    Zhitong·
    HK
    02656
    +1.38%

    Understanding the Market | 160 HEALTH surged over 10% in the closing session, reaching a new high since its listing, nearly doubling from its IPO price

    160 HEALTH surged over 10% in the late trading session, reaching a new high of HKD 35, nearly doubling from the offering price of HKD 11.89. As of the time of publication, it rose 10.16% to HKD 34.92, with a trading volume of HKD 35.7908 million. It is reported that 160 HEALTH is an experienced wholesale distributor of pharmaceutical and health products in China and a leading provider of integrated digital healthcare services. The company offers a variety of pharmaceutical and health products, as well as comprehensive digital healthcare solutions. Additionally, the company provides digital healthcare solutions through its online healthcare service platform - the 160 HEALTH platform, empowering participants across the entire healthcare industry chain. As of March 31, 2025, the 160 HEALTH platform has connected over 44,600 healthcare institutions since its establishment, including more than 14,400 hospitals (including 3,430 tertiary hospitals) and over 30,200 grassroots medical and health institutions

    Zhitong·
    HK
    02656
    +1.38%
    Zhitong·
    HK
    02656
    +1.38%
    © 2026 Longbridge｜Disclaimer